Cutis is a biotech spin-off from Karolinska Institutet redefining how we restore and maintain skin health and longevity through microbiome science. 

Our proprietary Reborn SkinBiome™ platform delivers shelf-stable, live bacterial strains and microbiome-derived actives that rebalance the skin ecosystem and improve resilience, radiance, and long-term skin health. 
We target common skin conditions like acne, eczema, and rosacea — without the use of antibiotics — and support the skin’s natural ability to age well. 

With a unique skin biobank, optimized culturing methods, and application-ready formats, we’re bridging 25+ years of academic discovery with innovation in cosmetics and dermatology. 

📈 Now raising €0.92M in seed funding to:
🔹 Finalize product development
🔹 Conduct proof-of-concept studies
🔹 Strengthen our team and scale our lab

📅 Opening August 15 — let’s connect!
📩 Contact: Ina Schuppe Koistinen